ALR Technologies SG Ltd (ALRTF)

[TheLastOneSitting]

ALRT Diabetes DD-Super-Package about today's SingHealth PR

Who ALRT is and what they offer:
ALRT offers a diabetes management solution in the form of one of the worlds most accurate meters & test strips at a fraction of the cost of competitors, and most importantly their revolutionary diabetes management software via app/web portal. They are FDA cleared and HIPA compliant, and have patented technology such as predictive A1C (which is a huge deal if you know anything about diabetes) and an insulin dose adjustment feature along with tons of usable and organized analytical data. It is also the only product on the market that solves the adherence to care problem (Must read article: https://morningconsult.com/opinions/improving-adherence-policies-could-save-4b-in-diabetes-care/). Take a look at one of their competitors (Livongo) who’s recent IPO on NASDAQ and has a market cap of over $2 Billion dollars with only 164,000 users and a far inferior product, at higher cost, that doesn’t address the #1 issue in diabetes which is adherence to care.

Who SingHealth is and why they are important:
Currently 60% of diabetics in the world live in Asia, and SingHealth is looked at as the leader in healthcare for all of Asia, their main hospital (SGH) was ranked #3 in the world (behind the Cleveland/Mayo Clinics) by NewsWeek magazine. SingHealth sees millions of patients per year and has a large network of hospitals, specialty centers and polyclinics. This 24 week trial obviously had to pass incredible medical and legal scrutiny by SingHealth and after doing so they are moving forward with ALRT as the PR states. They have recognized that ALRT is not just best in class in diabetes management, but they are in their own class by solving adherence to care and offering one of a kind features nobody else can provide.

Why ALRT's share price will be dollars not cents soon:
LVGO has 91M O/S, and a $2.4B market cap with only 164k users.
ALRT has 268M O/S, a $6.5M market cap and no users YET. They are pre-revenue and funded 100% by the CEO with no dilution to speak of for countless years.

When (because imo it will happen) SingHealth signs on during or after this trial ALRT will have it’s first users and it could be hundreds of thousands or even millions in a short amount of time as it spreads throughout the Asian healthcare systems. $1.00 a share would be just over a $250M market cap compared to their closest competitor (IMO) Livongo at $2.4B and only 164k users.

Not to mention I know from inquiring from the company that they are actively marketing ALRT to a number of entities and they are in talks with some as we speak but they will only announced signed agreements/deals/partnerships and not just talks, so we could see other breakthrough announcements/deals any day/week/month in the future! ALRT is in my opinion, the most undervalued stock on the market, with a proven history of legitimacy and a desperate need in the market for their technology.

Supporting links to my DD:

PR Link:
http://www.globenewswire.com/news-release/2020/02/11/1983001/0/en/ALR-Technologies-Partners-with-Singapore-General-Hospital-to-Conduct-a-Clinical-Pilot.html?ev=1

Adherence to care link:
“When he won the Nobel Prize in October, Dr. Richard Thaler proved that small idea can sometimes solve big problems. Thaler won for his research proving that small behavioral inducements (called “nudges”) can reap enormous benefits. There’s one particularly troubling area where the United States could use one of Dr. Thaler’s nudges: getting diabetes patients to follow doctor’s orders. Improving diabetes patients’ adherence to treatment plans could save taxpayers $4 billion per year in Medicaid spending, according to one estimate – to say nothing of their improved quality of life.” https://morningconsult.com/opinions/improving-adherence-policies-could-save-4b-in-diabetes-care/

Livongo stock / company / IPO info link:
https://www.forbes.com/sites/zinamoukheiber/2019/06/28/digital-health-company-livongo-files-for-an-ipo/#68f334e234a6

Diabetes statistic link:
“60% of diabetics in the world live in Asia” https://asiandiabetesprevention.org/what-is-diabetes/facts-and-figures

SingHealth info link:
“Singapore Health Services (commonly abbreviated as SingHealth) is Singapore's largest cluster of healthcare institutions. The cluster was formed in 2000 and consists of four public hospitals (including Singapore General Hospital, the oldest and largest hospital in the country), two community hospitals, five national specialty centers and a network of eight polyclinics.” https://en.wikipedia.org/wiki/SingHealth

SingHealth info link:
“Singapore has been ranked in sixth place in the world for innovation and is top in the Asia Pacific region. The city is already one of the most dynamic healthcare innovation hubs in the world and the World Competitiveness Yearbook indicates that the country has established one of the world's best healthcare infrastructures.” https://www.dailysabah.com/business/2016/10/22/singapore-likely-to-become-a-world-leader-in-healthcare-innovation

Hospital ranking link:
“3. Singapore General Hospital: "The island nation's largest health system, serving more than one million patients annually."”https://www.singhealth.com.sg/news/tomorrows-medicine/sgh-ranked-worlds-third-best-hospital-by-newsweek